Monthly Cost Breakdown: Wegovy vs Mounjaro Price Comparison
Why Is Wegovy Cheaper Than Mounjaro: Understanding Monthly Cost Structures
The fundamental reason why Wegovy appears cheaper than Mounjaro lies in their different market positioning and dose escalation schedules. Wegovy's semaglutide-based formula has been available longer, allowing for more competitive pricing structures, whilst Mounjaro's newer tirzepatide dual-agonist mechanism commands premium pricing. Your monthly costs with Wegovy start at £79.99 for the initial 0.25mg dose, creating an accessible entry point for patients beginning their weight management journey. This pricing advantage becomes particularly evident during the first 12 weeks of treatment, where Wegovy's escalation costs remain more predictable.
Understanding why Wegovy costs less than Mounjaro monthly also involves examining the dose progression schedules. Wegovy's four-month escalation from 0.25mg to 2.4mg maintenance follows a steady price increase: £79.99, £94.99, £99.99, £139.99, then £209.99 for maintenance. This structured approach allows patients to budget effectively, knowing their monthly costs will stabilise at £209.99 once they reach the therapeutic 2.4mg dose. Both treatments require prescription-only medicine status and clinical assessment through our GPhC-registered pharmacy (#9012878).
Wegovy Monthly Pricing Structure and Bundle Savings
EverydayMeds offers transparent Wegovy pricing with discount codes applied at checkout to ensure you receive the best value. New customers use code FIRST40, whilst returning customers benefit from DOSE25 for ongoing savings. Our single pen prices reflect the final costs: 0.25mg starter dose at £79.99, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 maintenance (2.4mg). These prices include professional prescriber review, next-day cold-chain delivery, and ongoing clinical support throughout your treatment journey.
Our bundle options provide convenience for planning ahead without the complexity of multiple orders. The Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first two months, whilst the Progress Duo (0.5mg & 1mg) at £189.99 spans weeks 5-12. For maintenance planning, the Ultimate Stability Trio provides three months of 2.4mg supply at £649.99, ensuring uninterrupted treatment. Each bundle includes the same cold-chain delivery and clinical oversight as individual pen orders.
Clinical Evidence Supporting Wegovy's Value Proposition
In clinical trials, patients taking Wegovy alongside diet and exercise achieved significant weight management results. The STEP 1 trial demonstrated approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 3 study showed approximately clinically studied weight loss when combined with intensive behavioural therapy, whilst STEP 5 sustained approximately clinically studied weight loss at two years.
Recent SELECT cardiovascular outcomes trial data revealed a 20% reduction in major cardiovascular events (HR 0.80) in patients receiving semaglutide. This clinical evidence supports Wegovy's position as a prescription-only medicine designed for comprehensive weight management, not just short-term results. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your clinical needs and budget considerations.
How Wegovy Works: GLP-1 Mechanism and Appetite Control
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support weight management. The medication works by binding to GLP-1 receptors in your brain's appetite centres, potentially reducing hunger signals and promoting feelings of satiety after smaller meals. This mechanism may help decrease food cravings and support portion control, making it easier to maintain a reduced-calorie diet. Unlike Mounjaro's dual GIP and GLP-1 action, Wegovy focuses specifically on GLP-1 pathways, which contributes to its established efficacy profile and pricing structure. The once-weekly injection schedule using Novo Nordisk's FlexTouch pen system provides consistent medication delivery throughout your treatment journey.
EverydayMeds Ordering Process: Assessment to Delivery
Starting Wegovy through EverydayMeds begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (express 24-hour service available), ensuring safe prescribing practices for this prescription-only medicine. Once approved, your Wegovy pen ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all regulations are met, from prescription verification to secure delivery. Ongoing support includes dose escalation guidance, side effect monitoring, and refill reminders to maintain treatment continuity.
Storage Advantages and Practical Considerations
Wegovy offers practical storage advantages that support consistent treatment compliance and reduce medication waste. The FlexTouch pens remain stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability proves valuable during travel, power outages, or busy schedules when refrigerator access becomes limited. Before first use, store Wegovy pens in your refrigerator at 2-8°C, and never freeze or shake the medication. The dose escalation schedule requires four months to reach maintenance levels, so proper storage ensures each pen maintains full potency throughout your treatment progression.
Why Wegovy Offers Better Monthly Value Than Mounjaro for UK Patients
Understanding why Wegovy provides superior monthly value compared to Mounjaro involves examining both immediate costs and long-term treatment sustainability. Wegovy's established market presence allows competitive pricing without compromising clinical effectiveness, particularly important for patients requiring ongoing maintenance therapy. The structured dose escalation creates predictable monthly budgeting, unlike some alternatives where pricing can fluctuate or become less accessible over time.
UK patients benefit from Wegovy's NICE TA875 recommendation, which supports its clinical value proposition alongside cost considerations. The medication's proven track record across multiple STEP trials, combined with accessible monthly pricing through EverydayMeds, creates a compelling value equation. Our discount codes FIRST40 and DOSE25 ensure both new and returning customers maintain competitive pricing throughout their weight management journey.
Start Your Wegovy Journey with Transparent Monthly Pricing
Beginning Wegovy treatment at EverydayMeds means accessing transparent, competitive monthly pricing without hidden costs or surprise increases. Our starter dose at £79.99 provides an accessible entry point, progressing predictably to £209.99 monthly maintenance costs once you reach therapeutic levels. Use discount code FIRST40 as a new customer, or DOSE25 for returning patients to ensure optimal value throughout your treatment. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and begin treatment with next-day delivery. Our qualified prescribers and ongoing clinical support ensure safe, effective weight management aligned with your individual needs and budget requirements.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
